255 related articles for article (PubMed ID: 35223835)
1. A Ferroptosis-Related Gene Prognostic Index Associated With Biochemical Recurrence and Radiation Resistance for Patients With Prostate Cancer Undergoing Radical Radiotherapy.
Feng D; Shi X; Xiong Q; Zhang F; Li D; Wei W; Yang L
Front Cell Dev Biol; 2022; 10():803766. PubMed ID: 35223835
[No Abstract] [Full Text] [Related]
2. A cellular senescence-related gene prognostic index for biochemical recurrence and drug resistance in patients with prostate cancer.
Feng D; Shi X; You J; Xiong Q; Zhu W; Wei Q; Yang L
Am J Cancer Res; 2022; 12(8):3811-3828. PubMed ID: 36119834
[TBL] [Abstract][Full Text] [Related]
3. An autophagy-related gene prognostic index predicting biochemical recurrence, metastasis, and drug resistance for prostate cancer.
Zhu WZ; Feng DC; Xiong Q; Shi X; Zhang FC; Wei Q; Yang L
Asian J Androl; 2023; 25(2):208-216. PubMed ID: 36412461
[TBL] [Abstract][Full Text] [Related]
4. A Gene Prognostic Index Associated With Epithelial-Mesenchymal Transition Predicting Biochemical Recurrence and Tumor Chemoresistance for Prostate Cancer.
Feng D; Shi X; Xiong Q; Zhang F; Li D; Yang L
Front Oncol; 2021; 11():805571. PubMed ID: 35096608
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Aldehyde Dehydrogenase 2 Represents a Potential Biomarker of Biochemical Recurrence in Prostate Cancer Patients.
Feng D; Zhu W; You J; Shi X; Han P; Wei W; Wei Q; Yang L
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144737
[TBL] [Abstract][Full Text] [Related]
6. Immune-related gene index predicts metastasis for prostate cancer patients undergoing radical radiotherapy.
Feng D; Zhu W; Shi X; Wang Z; Wei W; Wei Q; Yang L; Han P
Exp Hematol Oncol; 2023 Jan; 12(1):8. PubMed ID: 36635777
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799
[TBL] [Abstract][Full Text] [Related]
8. Developing an immune-related gene prognostic index associated with progression and providing new insights into the tumor immune microenvironment of prostate cancer.
Feng D; Zhang F; Li D; Shi X; Xiong Q; Wei Q; Yang L
Immunology; 2022 Jun; 166(2):197-209. PubMed ID: 35271752
[TBL] [Abstract][Full Text] [Related]
9. A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer.
Ke ZB; You Q; Sun JB; Zhu JM; Li XD; Chen DN; Su L; Zheng QS; Wei Y; Xue XY; Xu N
Front Cell Dev Biol; 2021; 9():774625. PubMed ID: 35071228
[No Abstract] [Full Text] [Related]
10. A Novel Four Mitochondrial Respiration-Related Signature for Predicting Biochemical Recurrence of Prostate Cancer.
Xia Z; Liu H; Fan S; Tu H; Jiang Y; Wang H; Gu P; Liu X
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675580
[TBL] [Abstract][Full Text] [Related]
11. Identification of senescence-related molecular subtypes and key genes for prostate cancer.
Feng DC; Zhu WZ; Shi X; Xiong Q; You J; Wei Q; Yang L
Asian J Androl; 2023; 25(2):223-229. PubMed ID: 36124532
[TBL] [Abstract][Full Text] [Related]
12. Energy Metabolism-Related Gene Prognostic Index Predicts Biochemical Recurrence for Patients With Prostate Cancer Undergoing Radical Prostatectomy.
Feng D; Shi X; Zhang F; Xiong Q; Wei Q; Yang L
Front Immunol; 2022; 13():839362. PubMed ID: 35280985
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria Dysfunction-Mediated Molecular Subtypes and Gene Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy.
Feng D; Shi X; Zhang F; Xiong Q; Wei Q; Yang L
Front Oncol; 2022; 12():858479. PubMed ID: 35463369
[TBL] [Abstract][Full Text] [Related]
14. The ferroptosis-related long non-coding RNAs signature predicts biochemical recurrence and immune cell infiltration in prostate cancer.
Liu C; Gao Y; Ni J; Chen S; Hu Q; Wang C; Hu M; Chen M
BMC Cancer; 2022 Jul; 22(1):788. PubMed ID: 35850679
[TBL] [Abstract][Full Text] [Related]
15. Identification of Ferroptosis-Associated Genes in Prostate Cancer by Bioinformatics Analysis.
Wo Q; Liu Z; Hu L
Front Genet; 2022; 13():852565. PubMed ID: 35860472
[No Abstract] [Full Text] [Related]
16. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
[No Abstract] [Full Text] [Related]
17. MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancer.
Lin BB; Lei HQ; Xiong HY; Fu X; Shi F; Yang XW; Yang YF; Liao GL; Feng YP; Jiang DG; Pang J
Comput Struct Biotechnol J; 2021; 19():4941-4953. PubMed ID: 34527198
[TBL] [Abstract][Full Text] [Related]
18. A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer.
Wang Y; Fan J; Chen T; Xu L; Liu P; Xiao L; Wu T; Zhou Q; Zheng Q; Liu C; Chan FL; Wu D
Front Endocrinol (Lausanne); 2022; 13():975623. PubMed ID: 36034466
[TBL] [Abstract][Full Text] [Related]
19. LTBP2 inhibits prostate cancer progression and metastasis via the PI3K/AKT signaling pathway.
Zhang X; Tian C; Cheng J; Mao W; Li M; Chen M
Exp Ther Med; 2022 Sep; 24(3):563. PubMed ID: 36034756
[TBL] [Abstract][Full Text] [Related]
20. Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients.
Feng D; Li L; Li D; Wu R; Zhu W; Wang J; Ye L; Han P
Eur J Med Res; 2023 Jul; 28(1):245. PubMed ID: 37480146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
